Dimerix

Dimerix Inventory/Revenue

The Inventory to Revenue Ratio of Dimerix (DXB.AX) as of Nov 4, 2026 is 501.01 %. In the previous year, Inventory to Revenue Ratio was 6.20 % — a change of 7,983.73% (higher).

Inventory/Revenue

501.01 %

YoY

7,983.73%

Last updated:

Inventory to Revenue Ratio of Dimerix is 2023 501.01 % . Inventory to Revenue Ratio of Dimerix was 2022 6.20 % . It decreases by 7,983.73% higher compared to the previous year.

The Dimerix Inventory/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory/Revenue
Date
Inventory/Revenue
Jan 1, 2016
-75.29 AUD
Jan 1, 2017
-104.07 AUD
Jan 1, 2018
-106.89 AUD
Jan 1, 2019
-88.11 AUD
Jan 1, 2020
4.60 AUD
Jan 1, 2021
2.67 AUD
Jan 1, 2022
6.20 AUD
Jan 1, 2023
501.01 AUD
The Dimerix Inventory/Revenue history
YEARInventory/RevenueYoY
501.01 %+7,983.73%
6.20 %+132.12%
2.67 %-41.93%
4.60 %-105.22%
-88.11 %-17.57%
-106.89 %+2.71%
-104.07 %+38.23%
-75.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Inventory to Revenue Ratio of Dimerix is 501.01 % in 2023.

Inventory to Revenue Ratio of Dimerix changed from 6.20 % to 501.01 %, representing a 7,983.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory to Revenue Ratio Dimerix since 2006 – with annual values, charts, and detailed analysis.

The Inventory/Revenue ratio shows what percentage of revenue is held as inventory. Rising ratios may indicate slowing demand or inventory management issues.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory to Revenue Ratio's Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Dimerix

All Key Metrics — Dimerix